[Osteoporosis prophylaxis in men? Adverse effects of total androgen blockade in carcinoma of the prostate].
Hüfner
M
M
Abteilung Gastroenterologie und Endokrinologie, Medizinische Klinik und Poliklinik, Georg-August-Universität, Göttingen.
D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014807:Vitamin D / Q000627:therapeutic use
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; D014807:Vitamin D; D002118:Calcium